Answers are grounded in this paper and cite their sources.
This study provides strong in vivo evidence for smooth muscle-to-macrophage transdifferentiation and supports an important role of SMC plasticity in atherogenesis. Targeting this type of SMC phenotypic conversion might be a novel strategy for the treatment of atherosclerosis, as well as other diseases with a smooth muscle component.
No takes yet. Share an insight, caveat, or question.
Feil et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: